A carregar...
Optimal Care for Patients with Anaplastic Lymphoma Kinase (ALK)–Positive Non–Small Cell Lung Cancer: A Review on the Role and Utility of ALK Inhibitors
The treatment of advanced non–small-cell lung cancer (NSCLC) has undergone a paradigm shift in the last decade. Molecular characterization of the disease has led to the rapid development of personalized medicine and swift delivery of targeted therapies to patients. The discovery of the anaplastic ly...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7425086/ https://ncbi.nlm.nih.gov/pubmed/32821158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S260274 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|